![A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study | Journal of Women's Health A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study | Journal of Women's Health](https://www.liebertpub.com/cms/10.1089/jwh.2015.5271/asset/images/medium/figure1.gif)
A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study | Journal of Women's Health
![Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_021_FP1215_T2.jpg.jpg)
Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner
![Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature | Lipids in Health and Disease | Full Text Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature | Lipids in Health and Disease | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12944-019-1182-5/MediaObjects/12944_2019_1182_Fig2_HTML.png)
Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature | Lipids in Health and Disease | Full Text
![Table 1 from Prescribed Daily Doses (PDDs) of Hypolipidaemic Agents in South Africa with Emphasis on HMG CoA Reductase Inhibitors | Semantic Scholar Table 1 from Prescribed Daily Doses (PDDs) of Hypolipidaemic Agents in South Africa with Emphasis on HMG CoA Reductase Inhibitors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c9eedbe38927fda118d3f7368ad657b72bc2a49f/2-Table1-1.png)
Table 1 from Prescribed Daily Doses (PDDs) of Hypolipidaemic Agents in South Africa with Emphasis on HMG CoA Reductase Inhibitors | Semantic Scholar
![Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_021_FP1215_T1.jpg.jpg)
Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner
![Approximate Equivalent Rosuvastatin Doses for Temporary Statin Interchange Programs | Semantic Scholar Approximate Equivalent Rosuvastatin Doses for Temporary Statin Interchange Programs | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/37efcaf1312c5ca35047d184682c7857630cce38/4-Table1-1.png)
Approximate Equivalent Rosuvastatin Doses for Temporary Statin Interchange Programs | Semantic Scholar
![Generic or intensive statin therapy: saving money or saving lives? - The British Journal of Cardiology Generic or intensive statin therapy: saving money or saving lives? - The British Journal of Cardiology](https://bjcardio.co.uk/wp-content/uploads/2015/08/Figure-11.png)
Generic or intensive statin therapy: saving money or saving lives? - The British Journal of Cardiology
![Therapeutics Initiative | [87] High dose versus standard dose statins in stable coronary heart disease Therapeutics Initiative | [87] High dose versus standard dose statins in stable coronary heart disease](https://www.ti.ubc.ca/wordpress/wp-content//uploads/2013/01/87-fig1.jpg)
Therapeutics Initiative | [87] High dose versus standard dose statins in stable coronary heart disease
Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study | PLOS ONE
Rosuvastatin newly funded for management of cardiovascular disease and familial hypercholesterolaemia | He Ako Hiringa
![IJMS | Free Full-Text | Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter? IJMS | Free Full-Text | Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?](https://www.mdpi.com/ijms/ijms-23-09326/article_deploy/html/images/ijms-23-09326-g003.png)